The phase 3 KEYNOTE-B21 study missed its primary end point, as pembrolizumab plus chemotherapy did not improve disease-free ...

Keytruda is already approved in patients with endometrial carcinoma that is microsatellite instability-high (MSI-H) or ...

Merck said on Thursday its therapy did not meet the main goal of disease-free survival in certain patients with endometrial ...

After a combination with Eisai’s Lenvima failed to improve survival in advanced disease in December, adjuvant Keytruda plus ...

Drug major Merck & Co., Inc. (MRK) announced Thursday that the Phase 3 KEYNOTE-B21 trial evaluating its anti-PD-1 therapy KEYTRUDA ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public ...

Dr. Ebony Hoskins, a board-certified gynecologic oncologist at MedStar Washington Hospital Center, said data showed combining immunotherapy with chemotherapy had improved progression-free survival.

Radiotherapy decisions should be made using refined genomic guidance, as recommended by 2021 updated international guidelines ...

Pesticides have gained negative attention in recent years owing to their links to biodiversity loss. But could pesticides ...

By Robb M. Stewart Merck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use ...

One such study has investigated if there is a link between pesticide use and endometrial cancer. Pesticides, also known as plant protection products (PPP), are used to control pests, weeds and ...

Proteomic signatures in blood plasma and cervicovaginal fluid for endometrial cancer detection. Study uncovers proteomic signatures in blood plasma and cervicovaginal fluid that could lead to non ...